SCHEMBL14083914

SCHEMBL14083914

O=C(Nc1ccc(F)cc1)c1ccc(-c2ncccc2Cl)cn1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 5/20 0.59
▸ RAB9A P51151 3/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ P4HTM Q9NXG6 2/20 0.49
▸ GRM4 Q14833 2/20 0.47
▸ GCGR P47871 2/20 0.47
▸ PTPN1 P18031 1/20 0.46
▸ PTPN6 P29350 1/20 0.46
▸ PTPN11 Q06124 1/20 0.46
▸ KCNQ3 O43525 2/20 0.45
▸ KCNQ2 O43526 2/20 0.45
▸ KCNQ5 Q9NR82 1/20 0.45
▸ KCNE1 P15382 1/20 0.45
▸ KCNQ1 P51787 1/20 0.45
▸ BACE1 P56817 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083056 0.90 TRPV1 (0.58) TRPV1RAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL14083912 0.88 TRPV1 (0.56) TRPV1RAB9ANPC1ALDH1A1P4HTM
SCHEMBL14083999 0.88 TRPV1 (0.59) TRPV1RAB9ANPC1ALDH1A1GAA
SCHEMBL14083962 0.88 KCNQ3 (0.54) TRPV1RAB9ANPC1GRM4KCNQ3
SCHEMBL14083943 0.87 TRPV1 (0.58) TRPV1SMN1; SMN2GRM4
SCHEMBL14083938 0.87 TRPV1 (0.79) TRPV1
SCHEMBL14084027 0.87 SMN1; SMN2 (0.53) TRPV1RAB9ANPC1SMN1; SMN2GRM4
SCHEMBL14083469 0.86 TRPV1 (0.78) TRPV1PTPN1PTPN6PTPN11KCNQ3
SCHEMBL14083929 0.85 TRPV1 (0.60) TRPV1RAB9ANPC1ALDH1A1GAA
SCHEMBL14083905 0.84 RAB9A (0.60) TRPV1RAB9ANPC1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 TRPV1 1/4885RAB9A 1914/4885NPC1 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback